Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Global Medical REIT Inc. (GMRE)
Delisted
6 Mar 2026
NYSE
All
(1)
US
(1)
NYSE
Primary
$
35.
74
-0.45
-1.2434%
$
478.13M
Market Cap
42.46
P/E Ratio
0.86%
Div Yield
92,285
Volume
0.25
Eps
$
36.19
Previous Close
Investors:
MC
Day Range
35.44
36.13
Year Range
29.05
45.75
Want to track
GMRE
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
News
Historical Data
Investors
Global Medical REIT Inc. (GMRE) Statistics
Valuation metrics
Market Cap
478.13M
Enterprise value
1.29B
Trailing P/E (ttm)
-
Forward P/E
299.83
PEG ratio
299.83
Price/Sales (ttm)
6.77
Price/Book (mrq)
1.18
Enterprise Value/Revenue
8.88
Enterprise Value/EBITDA
14.69
Overview
Shares outstanding
13.23M
Float
12.59M
Shares short
645.25K
% Held by insiders
0.06%
% Held by institutions
0.68%
Average volume (10 days)
82.38K
Average volume (90 days)
105.31K
Price summary
52-Week low
29.05
52-Week high
45.75
Beta
1.2
50-Day moving average
35.24
200-Day moving average
34.14
Dividends and splits
Forward annual dividend rate
1
Forward annual dividend yield
0.0287%
Trailing annual dividend rate
5
Trailing annual dividend yield
0.1436%
5-Year annual dividend yield
9.11%
Payout ratio
11.14
Dividend Date
12 Jun 2026
Ex-Dividend Date
20 May 2026
Last split factor
1:5
Last split Date
22 Sep 2025
Financials
Fiscal year
Fiscal year ends
31 Dec 2024
Most recent quarter (mrq)
31 Dec 2025
Profitability
Profit margin
0.02%
Operating margin
0.24%
Operational effectiveness
Return on assets
0.02%
Return on equity
0%
Income Statement
Revenue (ttm)
144.83M
Revenue per share (ttm)
10.83
Quarterly revenue growth (yoy)
0.09%
Gross profit (ttm)
144.67M
EBITDA
95.66M
Net income to common (ttm)
-3.32M
Diluted EPS (ttm)
-0.26
Quarterly earnings growth (yoy)
0.09%
Balance Sheet
Total cash (mrq)
14.59M
Total cash per share (mrq)
1.09
Total debt (mrq)
723.14M
Total Debt/Equity (mrq)
142.96
Current ratio (mrq)
1.91%
Book value per share (mrq)
30.61
Cash Flow
Cash flow statement
72.5M
Levered free cash flow (LFCF)
66.02M